In this video interview, Kent Thoelke, CEO of Paradigm Health, explains why patient cost barriers and site infrastructure challenges must be solved together to close the participation gap in community and rural clinical trials.
|Articles|January 23, 2023
People and Business News —1/23
Advertisement
People News
Yolanda Barbachano has been appointed as Head of Statistics for Quanticate.
Massive Bio announced the addition of two executives to its C-suite: Özgür “Oz” Huner as their first Chief Product Officer, and Erkan Terzi has been promoted to Chief Marketing Officer.
Encapsia announced the appointment of Francis Destin as its new Chief Operating Officer.
Dawn Sauro has been named as Elligo’s Chief Operating Officer.
Trialbee announced the addition of Kristopher Sarajian as their new Vice President of Marketing.
Greenphire has appointed Owen Newman as the Chief Financial Officer.
Emmes appointed Matt Honan as Vice President and Head of Corporate Development.
News
NNIT has received its recertification as a Veeva Premiere Services Partner – Development Cloud.
Recognition
Suvoda LLC surpassed 1,000 clinical trials in 2022 as study deployments surged nearly 20%.
Advertisement
Related to this article
Patients don’t experience primary endpoints, so trials that stop at biomarkers and rigid rating scales risk declaring success while leaving daily burden untouched, and digital tools only deliver meaningful evidence when they are co-designed with patients and deployed with restraint.
Aardvark released exploratory data from its stopped Phase 3 HERO trial in Prader-Willi syndrome after FDA lifted the hold, and plans a redesigned Phase 3.
Clinical trials capture data faster than ever, but the real bottleneck is the distance between data capture and a decision teams can trust.
In today’s ACT Brief, we examine why the future of AI in trials is a trusted orchestration system rather than a single model, how coordinators rate eSource-enabled workflows, and what a bipartisan bill proposes for reusable trial networks.
The Faster Clinical Trials Act would create an FDA Center for Clinical Trial Innovation and aims to cut trial costs and enrollment time by at least 30%.
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clinical Trials Do Not Have a Data Problem, They Have a Decision-Readiness Problem
2
Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology
3
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
4
ACT Brief: Orchestrated AI Clinical Environments, eSource Coordinator Satisfaction, and Faster Clinical Trials Act
5